The medium- and high-dose groups had a decreased risk in comparison with the low-dose group, but the result did not reach statistical significance [medium: HR 0.92 (0.82–1.04), aHR 0.92 (0.82–1.04); high: HR 0.95 (0.82–1.09), aHR 0.91 (0.79–1.05)].
← all excerpts
Lack of association between erythropoietin treatment and risk of depression in patients with end-stage kidney disease on maintenance dialysis: a nationwide database study in Taiwan.
1
—
—